» Articles » PMID: 17905609

Posttranslational Processing of Hepcidin in Human Hepatocytes is Mediated by the Prohormone Convertase Furin

Overview
Specialty Hematology
Date 2007 Oct 2
PMID 17905609
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Hepcidin is encoded as an 84 amino acid prepropeptide containing a typical N-terminal 24 amino acid endoplasmic reticulum targeting signal sequence, and a 35 amino acid proregion (pro) with a consensus furin cleavage site immediately followed by the C-terminal 25 amino acid bioactive iron-regulatory hormone (mature peptide). We performed pulse-chase studies of posttranslational processing of hepcidin in human hepatoma HepG2 cells and in primary human hepatocytes induced with bone morphogenic protein (BMP-9). In some experiments, the cells were treated with the furin protease inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (CMK) or furin siRNA. In the absence of furin inhibitor, hepcidin was found to be processed in less than 1 h and secreted as a 3 kDa form reactive with anti-mature but not anti-pro antibody. In the presence of furin inhibitors or furin siRNA, a 6 kDa form reactive with both anti-pro and anti-mature antibody was rapidly secreted into the medium. Processing was not affected by inhibitors of the hypoxia inducible factor (HIF) pathway, or by treatment with 30 microM holo- or apo-transferrin. In conclusion, the hepatic prohormone convertase furin mediates the posttranslational processing of hepcidin. The proteolytic cleavage of prohepcidin to hepcidin is not regulated by iron-transferrin or the HIF pathway.

Citing Articles

A Novel Hepcidin Isoform Jd-Hep from the Sin Croaker Johnius dussumieri (Cuvier, 1830): Recombinant Expression and Insights into the Antibacterial Property and Modes of Action.

Anju M, Archana K, Musthafa S, Anooja V, Athira P, Neelima S Mar Biotechnol (NY). 2025; 27(2):52.

PMID: 39969620 DOI: 10.1007/s10126-025-10426-z.


Predictive Value of Serum Hepcidin Levels for the Risk of Incident End-Stage Kidney Disease in Patients with Chronic Kidney Disease: The KNOW-CKD.

Suh S, Oh T, Choi H, Kim C, Bae E, Ma S Kidney Dis (Basel). 2024; 10(6):492-503.

PMID: 39664339 PMC: 11631166. DOI: 10.1159/000542057.


Preterm Piglets Born by Cesarean Section as a Suitable Animal Model for the Study of Iron Metabolism in Premature Infants.

Wang X, Lenartowicz M, Mazgaj R, Ogluszka M, Szkopek D, Zaworski K Int J Mol Sci. 2024; 25(20).

PMID: 39456997 PMC: 11508764. DOI: 10.3390/ijms252011215.


Social defeat stress impairs systemic iron metabolism by activating the hepcidin-ferroportin axis.

Kasahara E, Nakamura A, Morimoto K, Ito S, Hori M, Sekiyama A FASEB Bioadv. 2024; 6(8):263-275.

PMID: 39114446 PMC: 11301257. DOI: 10.1096/fba.2024-00071.


Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?.

Shen X, Yu Z, Wei C, Hu C, Chen J Am J Physiol Endocrinol Metab. 2024; 326(6):E767-E775.

PMID: 38506752 PMC: 11376490. DOI: 10.1152/ajpendo.00260.2023.


References
1.
Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

2.
Pak M, Lopez M, Gabayan V, Ganz T, Rivera S . Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006; 108(12):3730-5. PMC: 1895477. DOI: 10.1182/blood-2006-06-028787. View

3.
Fein E, Merle U, Ehehalt R, Herrmann T, Kulaksiz H . Regulation of hepcidin in HepG2 and RINm5F cells. Peptides. 2007; 28(5):951-7. DOI: 10.1016/j.peptides.2007.01.016. View

4.
Tiker F, Celik B, Tarcan A, Kilicdag H, Ozbek N, Gurakan B . Serum pro-hepcidin levels and relationships with iron parameters in healthy preterm and term newborns. Pediatr Hematol Oncol. 2006; 23(4):293-7. DOI: 10.1080/08880010600629213. View

5.
Steiner D . The proprotein convertases. Curr Opin Chem Biol. 1998; 2(1):31-9. DOI: 10.1016/s1367-5931(98)80033-1. View